Table 2. Univariate and multivariate analyses of overall survival for the SEER cohort.
Prognostic factor | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
P value | HR | 95% CI | P value | HR | 95% CI | ||
Age, years | <0.001 | 0.5 | 0.484–0.517 | <0.001 | 0.412 | 0.399–0.426 | |
Sex | <0.001 | 0.948 | 0.921–0.976 | <0.001 | 0.92 | 0.894–0.947 | |
Location | <0.001 | 0.82 | 0.797–0.845 | <0.001 | 0.871 | 0.846–0.897 | |
pT stage | <0.001 | 2.647 | 2.542–2.756 | <0.001 | 1.667 | 1.597–1.739 | |
pN stage | <0.001 | 1.9 | 1.868–1.933 | <0.001 | 1.458 | 1.430–1.488 | |
pM stage | <0.001 | 3.989 | 3.873–4.109 | <0.001 | 3.047 | 2.939–3.159 | |
Perineural invasion | <0.001 | 1.128 | 1.112–1.145 | <0.001 | 1.03 | 1.014–1.047 | |
Tumor deposit | <0.001 | 2.685 | 2.594–2.780 | <0.001 | 1.411 | 1.358–1.465 |
SEER, Surveillance Epidemiology and End Results; HR, hazard ratio; CI, confidence interval.